Lungwort and the Doctrine of Signatures

Some herbs are named for where they grow, some for who described them, and a few for what they are supposed to do. Lungwort belongs to a fourth and narrower category: it is named for what somebody thought it looked like. And the resemblance was not incidental — it was taken as the reason to use the plant. Strip away the name and there is no independent tradition of anyone noticing that this particular woodland herb helped a cough. The name came first, and the indication came out of the name.

Across this site's herb pages, that pattern turns up repeatedly and usually in diluted form: a name nudges expectations, a tradition supplies some real observation alongside it. Lungwort is the clearest case we have found of the pure version. It is very close to a controlled demonstration of how the doctrine of signatures generated indications, because the same theory assigned two unrelated organisms from different kingdoms to the same organ, using two different visual features, and was satisfied both times.

This page takes the doctrine seriously rather than laughing at it. It was a coherent theory held by intelligent people for two centuries, it left a permanent mark on the vocabulary of plants, and there is a respectable modern argument that it was less a discovery method than a memory system. None of that makes it evidence. The aim here is to show exactly what work the name is doing, so that everything on the other pages in this section reads correctly.

Table of Contents

  1. What the Doctrine Actually Claimed
  2. Pulmonaria: The Latin Name Is the Argument
  3. The Lichen Got the Same Verdict From a Different Shape
  4. Our Lady's Milk Drops: The Same Spots, Read Differently
  5. What “officinalis” Records, and What It Does Not
  6. When the Doctrine Got Lucky, and What Kind of Luck It Was
  7. The Strongest Defence: Signatures as a Memory System
  8. Why It Persuaded: Self-Limiting Illness
  9. Names Travel Between Species
  10. What a Signature Can Never Tell You
  11. Modern Echoes of Signature Reasoning
  12. Does the Name Imply a Safety Profile?
  13. Key Research Papers
  14. Connections

What the Doctrine Actually Claimed

The doctrine of signatures held that the natural world had been marked, deliberately, with legible signs of its intended use. A plant's shape, colour, texture, habitat or sap was a signatura — a signature — placed there so that a careful observer could read off which part of the human body it was meant to treat. The theory was theological before it was medical: if a benevolent creator had provided remedies, it would be unreasonable to hide them, so they must be labelled.

The idea's history is longer and messier than the potted version suggests. Reasoning from resemblance appears in classical and medieval sources long before anyone systematised it. Giambattista della Porta's Phytognomonica of 1588 organised plants by the body parts they resembled. Paracelsus is the figure usually credited with putting the principle at the centre of medicine in the early sixteenth century, and the mystic Jakob Böhme gave it its most complete theological statement in De Signatura Rerum (1621). In English it was popularised by William Coles, whose Art of Simpling (1656) and Adam in Eden (1657) argued the case explicitly. Attribution of the idea to any single originator is contested, and we are not going to pretend otherwise.

What matters is the structure of the inference, which is worth writing out because its failure is not obvious from inside:

  1. Observe that a plant resembles an organ, a symptom, or a disease.
  2. Conclude that the resemblance was placed there as a sign.
  3. Conclude that the plant therefore treats that organ or disease.
  4. Give the plant a name recording the conclusion.
  5. Thereafter, cite the name as the reason for the use.

Step five is the trap, and it is the one still operating today. By the time the name is in circulation, the original inference is invisible. “Lungwort” looks like a summary of experience. It is a summary of a resemblance.

Pulmonaria: The Latin Name Is the Argument

With Pulmonaria officinalis the chain is unusually easy to trace, because nobody hid it. The leaves are irregularly blotched with pale spots on dark green, and to early modern European observers that mottling suggested a lung — specifically an unhealthy lung, patchy and marked. The genus name was built from pulmo, Latin for lung. The English name is a direct translation: wort is from Old English wyrt, meaning simply a plant or root put to use, so lungwort means lung-plant.

Note carefully what is not in that account. There is no report of a patient. There is no comparison between people who took the plant and people who did not. There is no account of a herbalist trying it for a dozen complaints and finding it worked for one. The reasoning runs entirely from the appearance of the leaf to the name of the organ, and the herbal indication was then read back out of the name.

It is also worth noticing how bad the resemblance is on any literal reading. A lung is not spotted. Consolidated, tuberculous or emphysematous lung tissue is mottled in various ways, and that is presumably the intended reference, but there is no version of lung anatomy that specifically resembles white flecks scattered across a green leaf. The resemblance is not observed so much as constructed — which becomes obvious in the next section.

The Lichen Got the Same Verdict From a Different Shape

This is the part that makes lungwort a better test case than any other name on this site.

As the identity page sets out, a second organism carries the same name: the lichen Lobaria pulmonaria, a fungus-alga-cyanobacterium partnership that grows in leathery lobes on old tree bark. It too was assigned to the lung. But it was assigned on a completely different visual feature: not spots, but the raised network of ridges and sunken pits across its upper surface, which was read as the chambered interior of a lung, together with the deeply lobed outline suggesting the lobes of the organ.

Set the two side by side and consider what the method has just demonstrated:

A rule of inference that accepts both “spotted” and “pitted and lobed” as signs of the same organ, in organisms with nothing in common, is not detecting anything about the organisms. It is detecting the expectation of the observer. Two independent applications, two different premises, one predetermined conclusion. That is about as close as history gets to running the experiment for us.

The same convergence shows up in the pharmacy names. The plant was Pulmonariae herba; the lichen was Lichen pulmonarius, earlier Sticta pulmonacea. Both got pulmo in the name, from different starting points, for the same reason.

Our Lady's Milk Drops: The Same Spots, Read Differently

There is a second, gentler tradition attached to exactly the same feature of exactly the same plant. In it, the pale blotches on the leaves are drops of the Virgin Mary's milk, spilled while she nursed — hence the folk names Our Lady's milk drops, Mary's tears and their equivalents in several European languages.

Two readings, one leaf. The spots meant diseased lung tissue to a physician and spilled milk to a village. We are not going to claim which reading came first, or that one caused the other; folk-name etymologies are frequently uncertain, sometimes contested, and occasionally tidied up after the fact by later writers.

What the pair establishes is the load-bearing point of this page: the signature was supplied by the observer, not by the plant. Nothing about a white blotch on a green leaf selects between milk and lung. Whoever needed a lung remedy saw a lung; whoever was telling a Marian story saw milk. A method whose output depends that completely on what the reader brought with them cannot generate knowledge about pharmacology, however sincerely it is applied.

It is worth adding that the milk reading did some work of its own. In other plants the same logic produced galactagogue claims — milk thistle's veined leaves being the obvious example, another white-marked leaf read as milk. The site's Self-Heal naming page works through the general mechanism at length, and rather than re-derive it here we will point you there: it is the same phenomenon, one species over.

What “officinalis” Records, and What It Does Not

The species epithet is worth a paragraph because it is routinely over-read. Officinalis comes from officina, the storeroom of a monastery or apothecary — the place where prepared drugs were kept. A plant called officinalis is a plant that was stocked.

That is a historical fact about inventory, not a verdict about efficacy. Borago officinalis, Symphytum officinale, Verbena officinalis, Salvia officinalis, Melissa officinalis, Althaea officinalis and Pulmonaria officinalis all carry it, and they range from thoroughly useful to actively hazardous. Comfrey — Symphytum officinale — is the sharpest illustration: it was stocked for centuries and is now restricted for internal use in several countries because of its alkaloid content, as the site's comfrey page details.

So Pulmonaria officinalis decodes as “the lung-plant that the apothecary kept in stock.” Both halves of the binomial describe a decision made by people, and neither describes a property of the plant.

When the Doctrine Got Lucky, and What Kind of Luck It Was

The fair objection to everything above is that the doctrine sometimes landed on a plant that really does something. That is true, and it deserves a proper answer rather than a dismissal.

The answer has two parts. First, the base rate. A very large proportion of plants contain compounds with measurable biological activity — alkaloids, glycosides, tannins, terpenes, phenolics. Any selection method whatsoever, including choosing at random, will therefore pick out “active” plants at a decent rate. The doctrine's apparent successes are consistent with that base rate and do not require the theory to be true. To credit the method you would need it to beat chance, and nobody has ever shown that it does.

Second, and more interesting: where a signature plant does turn out to be active, the direction is usually wrong. Two examples make the point unusually well, and both are well documented in the modern literature:

Neither example is an argument that traditional plant medicine is worthless — plenty of it is not. They are arguments about the specific inference. A method that identifies plants by resemblance selects for attention, not for benefit, and attention lands on toxins as readily as on remedies. Lungwort, as it happens, got a mild plant. That is luck of a third kind and no credit to the reasoning.

One more example belongs here because it connects directly to lungwort's chemistry. Lithospermum, another borage-family genus, is named from the Greek for “stone seed” after its hard white nutlets, and was accordingly used for urinary stones — a textbook signature. The compound class named after that genus, the lithospermic acids, is among the caffeic-acid derivatives actually reported in Pulmonaria leaves. So a signature-derived plant name is embedded in the modern chemical vocabulary of lungwort. The name travelled into the laboratory; the indication did not.

The Strongest Defence: Signatures as a Memory System

The most serious modern rehabilitation of the doctrine does not argue that it worked. It argues that it was never really a discovery method in the first place.

On this reading — associated with the ethnobotanist Bradley Bennett's paper in Economic Botany (2007), which asks directly whether the doctrine explains medicinal plant discovery or the dissemination of knowledge — the resemblances were largely attached to plants whose uses were already established by trial and error, and they functioned as a mnemonic. In a world of limited literacy and enormous local pharmacopoeias, a memorable visual hook is a powerful way to transmit “this one is for the chest” to an apprentice. The signature was a label on a drawer, not the reason the drawer's contents were chosen.

This is a genuinely good argument and it explains two things at once: why the doctrine felt so productive to its users, and why it has no predictive power. A labelling system can be highly effective at preserving knowledge while being incapable of generating any. It also predicts exactly what we observe — signatures assigned retrospectively, sometimes two different ones to the same feature, with no consistency in which features count.

But it cuts the other way for lungwort specifically, and this is the honest complication. If signatures were usually retrospective labels on empirically-derived uses, then lungwort is the awkward case where there is no visible empirical use underneath the label. Nobody has produced a pre-signature tradition of using Pulmonaria for the chest. For this plant the resemblance really does look like the origin of the indication rather than a mnemonic for it — and the fact that the same reasoning independently annexed a lichen to the same organ supports that reading.

Why It Persuaded: Self-Limiting Illness

Once a plant is in the pharmacopoeia, experience appears to confirm it, and it is important to understand why that experience was sincere rather than fraudulent.

Acute coughs get better. The overwhelming majority of acute coughs accompanying a common cold resolve on their own within one to three weeks, whatever is done about them. A herbalist who gives lungwort tea to a hundred coughing patients will see the great majority improve, and will have no comparison group. Every single recovery reads as a success. This is the same mechanism the Self-Heal page identifies for wound remedies — minor cuts heal whatever the poultice contains — and it is why traditions built on uncontrolled observation of self-limiting conditions accumulate confident, mutually reinforcing testimony for inert treatments.

Three further factors stack on top of it for cough specifically, and all three are documented in the modern cough literature discussed on the respiratory page:

  1. Cough is unusually placebo-responsive. Trials of cough remedies routinely record large improvements in the placebo arm, and the pharmacological effect of the active drug is often the smaller part of the total response.
  2. Sweetness itself suppresses cough. A warm sweetened infusion is not an inert vehicle; sweet taste appears to raise the cough threshold through its own reflex mechanism. Traditional lungwort preparations were teas and honey syrups.
  3. The soothed throat is a real sensation. A warm mucilaginous drink genuinely coats the pharynx and genuinely feels better. That the sensation is real does not make it a treatment for a lower-airway illness — a distinction the respiratory page insists on.

None of this is an accusation against the herbalists. Nobody had invented the control group. It is a reason their conclusions cannot function as data now.

Names Travel Between Species

The other thing folk names do, besides making claims, is migrate. The site's Self-Heal page documents how woundwort and allheal are shared between plants that are not close relatives — Prunella, Stachys, Valeriana, mistletoe and others — so that a historical reference to “woundwort” frequently cannot be pinned to a species at all.

Lungwort is that phenomenon at maximum amplitude. A shared name between two mints is a nuisance. A shared name between a flowering plant and a lichenised fungus is a category error preserved in the vocabulary. And it arises for the same reason: when a name records a resemblance rather than a lineage, anything that resembles the same thing qualifies. Resemblance is not exclusive; ancestry is.

This is why the practical advice on these pages is monotonous and unavoidable: use the binomial. A common name that was generated by resemblance can never be trusted to identify an organism, because that is not the job it was built for.

What a Signature Can Never Tell You

Suppose, for argument, that the doctrine of signatures were true and that lungwort really were marked for the lung. It would still leave every practical question unanswered. A resemblance carries no information about:

  1. Which species. The genus holds a dozen or more, several nearly indistinguishable, and the garden plants are mostly hybrids.
  2. Which part. Leaf, flowering top, whole herb or root — a distinction that turns out to matter enormously here, because the alkaloids of concern are reported to concentrate in the roots.
  3. Which preparation. Water infusion, alcohol tincture, syrup, poultice. These extract different fractions; alcohol precipitates mucilage, so a tincture is the wrong preparation for a demulcent claim entirely.
  4. What dose. No signature has ever specified grams.
  5. For how long. The difference between a five-day course and a daily habit is the whole of the alkaloid question.
  6. By what route. A swallowed infusion is a different intervention from an inhaled steam or a topical compress.
  7. What toxicity. Signatures mark benefit. Nothing in the theory generates warnings, which is precisely how Aristolochia entered obstetrics.
  8. What interactions. No sixteenth-century framework can address a herb taken alongside a prescription drug.
  9. Who must avoid it. Pregnancy, breastfeeding, liver disease, childhood — all invisible to the method.

Every one of those blanks has to be filled from somewhere else, and for lungwort most of them are still empty. The safety page lists what is missing as a numbered set of findings rather than leaving the reader to infer it.

Modern Echoes of Signature Reasoning

It would be comfortable to file the doctrine under history. The structure survives, though, usually with a molecule standing in for the shape. Some current examples, offered without pretending they are all equally bad:

Does the Name Imply a Safety Profile?

This site checks a specific question on every herb whose name makes a claim: does the name imply something about safety that the plant does not deliver? For motherwort the answer is yes and it is important — “mother” historically meant the uterus, so the name implies a use in pregnancy while the etymology implies a uterine action that is a reason to avoid it. We ran the same check here, and report the result whichever way it comes out.

For lungwort the answer is largely no, with one indirect exception. “Lungwort” and Pulmonaria name an organ and nothing else. They imply no reassurance about pregnancy, no gentleness, no suitability for children, and no statement about the liver. The name is a bare indication, not a smuggled safety claim. That is a checked-and-clear finding and it is worth stating, because a reader arriving from the motherwort or comfrey pages may reasonably expect otherwise.

The exception is real but indirect. A name that confidently assigns a herb to the lungs invites use for chest illness — and chest illness is a category that contains pneumonia, tuberculosis, pulmonary embolism, heart failure and lung cancer alongside the self-limiting cough. The hazard of “lungwort” is therefore not toxicological but a matter of delayed care: breathlessness, fever, coughing blood, weight loss, or a cough that outlasts a few weeks are reasons to be examined, not reasons to brew a woodland herb whose respiratory evidence is, as the next page documents, absent.

The honest summary of the name, then: Pulmonaria officinalis means “the spotted lung-plant kept in the apothecary's store.” It records a resemblance and an inventory decision. It records no trial, no observation of outcomes, and no safety assessment — and neither does the identical claim built into the name of a lichen from an entirely different kingdom.

Back to Table of Contents

Key Research Papers

Historical sources are named in the text above; sixteenth- and seventeenth-century herbals are not indexed in PubMed, and scanned originals are best reached through the Biodiversity Heritage Library. The modern literature below is cited by title or topic search, with the organism or subject labelled.

  1. [Doctrine of signatures, ethnobotany] Bradley Bennett, “Doctrine of Signatures: An Explanation of Medicinal Plant Discovery or Dissemination of Knowledge?”, Economic Botany, 2007 — PubMed topic search. The strongest modern statement of the mnemonic reading. Economic Botany is patchily indexed in PubMed, so a title search may not resolve; the paper is real and widely cited in the ethnobotanical literature.
  2. [Chelidonium majus] “Acute hepatitis induced by greater celandine (Chelidonium majus),” Gastroenterology, 1999 — PubMed. The signature pointed at the liver; the plant reached it as a hepatotoxin.
  3. [Chelidonium majus] The wider case series and regulatory-assessment literature on celandine liver injury — PubMed topic search.
  4. [Aristolochia] Aristolochic acid nephropathy and its link to Balkan endemic nephropathy — PubMed topic search. A large and unambiguous body of human evidence.
  5. [Aristolochia] Aristolochic acid as a human carcinogen in urothelial cancer — PubMed topic search. Includes the mutational-signature work that tied specific tumours to the exposure.
  6. [Euphrasia] Eyebright — another pure signature name, another empty evidence base — PubMed topic search. Useful as a control: the doctrine named it for the eye and nothing followed.
  7. [Pulmonaria officinalis] Krzyżanowska-Kowalczyk and colleagues, “Novel Phenolic Constituents of Pulmonaria officinalis L. LC-MS/MS Comparison of Spring and Autumn Metabolite Profiles,” Molecules, 2018 — PubMed. The plant's actual chemistry, which has no relationship to lungs.
  8. [Rosmarinic acid, compound level] Amoah and colleagues, “Rosmarinic Acid — Pharmaceutical and Clinical Aspects,” Planta Medica, 2016 — PubMed. A compound shared with dozens of unrelated plants, which is why compound-level findings are not lungwort findings.
  9. [Boraginaceae] Lithospermic and salvianolic acids in borage-family and related plants — PubMed topic search. The compound class whose name descends from a signature-derived genus name.
  10. [Cough, methodology] Ronald Eccles, “The powerful placebo in cough studies?”, Pulmonary Pharmacology & Therapeutics, 2002 — PubMed. Why uncontrolled experience of a cough remedy is close to uninformative.
  11. [Cough, methodology] Eccles, “Mechanisms of the placebo effect of sweet cough syrups,” Respiratory Physiology & Neurobiology, 2006 — PubMed. Sweetness is an active ingredient, which matters for a herb traditionally given as honey syrup.
  12. [Cough, natural history] Cochrane reviews of over-the-counter cough preparations in community settings — PubMed topic search. Establishes both the self-limiting course and the size of the placebo response.

Back to Table of Contents

Connections

Back to Table of Contents